# naproxen sodium pm

NDC: 37808-264
Generic name: diphenhydramine hydrochloride, naproxen sodium
Labeler / Manufacturer: H E B
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20201013

FDA application: ANDA208499

## Active ingredients

- DIPHENHYDRAMINE HYDROCHLORIDE: 25 mg/1
- NAPROXEN SODIUM: 220 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"37808-264"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=37808-264
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4281faf5-7182-404f-9f53-3d9ea0354a18